Apollomics, Inc.
General ticker "APLM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $9.2M (TTM average)
Apollomics, Inc. follows the US Stock Market performance with the rate: 31.7%.
Estimated limits based on current volatility of 8.7%: low 14.65$, high 17.44$
Factors to consider:
- Total employees count: 43 as of 2022
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [19.73$, 102.12$]
- 2024-12-30 to 2025-12-30 estimated range: [7.48$, 37.44$]
Short-term APLM quotes
Long-term APLM plot with estimates
Financial data
| YTD | 2023-12-31 |
|---|---|
| Operating Revenue | $0.82MM |
| Operating Expenses | $54.83MM |
| Operating Income | $-54.01MM |
| Non-Operating Income | $-118.58MM |
| Interest Expense | $0.15MM |
| R&D Expense | $34.19MM |
| Income(Loss) | $-172.59MM |
| Taxes | $0.01MM |
| Profit(Loss)* | $-172.60MM |
| Stockholders Equity | $41.23MM |
| Assets | $55.39MM |
| Operating Cash Flow | $-43.21MM |
| Capital expenditure | $0.01MM |
| Investing Cash Flow | $21.36MM |
| Financing Cash Flow | $21.23MM |
| Earnings Per Share** | $-232.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.